Objective. A previous sham-controlled multinational study demonstrated the short-term efficacy and safety for xerostomia treatment of an intraoral device that delivers electrostimulation to the lingual nerve. The objective of this study was to test the hypothesis that those beneficial effects would be sustained over an 11-month period. Study Design. The device was tested on a mixed sample of 94 patients with xerostomia in an open-label, uncontrolled, prospective multicenter trial. Statutory outcome assessments were done at 5th, 8th, and 11th months and analyzed by multiple comparisons. Results. Improvements achieved at month 5 from baseline were sustained throughout the follow-up period for the primary outcome, xerostomia severity, and the secondary outcomes resting whole salivary flow rate, xerostomia frequency, oral discomfort, and difficulties in speech, swallowing, and sleeping. No significant side effects were detected. Conclusions. The beneficial effects of a removable intraoral electrostimulating device were sustained for an 11-month period.

Alajbeg, I., Falcão, D.P., Tran, S.D., Martín-Granizo, R., Lafaurie, G.I., Matranga, D., et al. (2012). Intraoral electrostimulator for xerostomia relief: a long-term, multicenter, open-label, uncontrolled, clinical trial. ORAL SURGERY, ORAL MEDICINE, ORAL PATHOLOGY AND ORAL RADIOLOGY, 113(6), 773-781 [10.1016/j.oooo.2012.01.012].

Intraoral electrostimulator for xerostomia relief: a long-term, multicenter, open-label, uncontrolled, clinical trial

MATRANGA, Domenica;MELILLI, Dario;CAMPISI, Giuseppina;PADERNI, Carlo;
2012-01-01

Abstract

Objective. A previous sham-controlled multinational study demonstrated the short-term efficacy and safety for xerostomia treatment of an intraoral device that delivers electrostimulation to the lingual nerve. The objective of this study was to test the hypothesis that those beneficial effects would be sustained over an 11-month period. Study Design. The device was tested on a mixed sample of 94 patients with xerostomia in an open-label, uncontrolled, prospective multicenter trial. Statutory outcome assessments were done at 5th, 8th, and 11th months and analyzed by multiple comparisons. Results. Improvements achieved at month 5 from baseline were sustained throughout the follow-up period for the primary outcome, xerostomia severity, and the secondary outcomes resting whole salivary flow rate, xerostomia frequency, oral discomfort, and difficulties in speech, swallowing, and sleeping. No significant side effects were detected. Conclusions. The beneficial effects of a removable intraoral electrostimulating device were sustained for an 11-month period.
Settore MED/28 - Malattie Odontostomatologiche
Settore MED/01 - Statistica Medica
Settore MED/50 - Scienze Tecniche Mediche Applicate
Alajbeg, I., Falcão, D.P., Tran, S.D., Martín-Granizo, R., Lafaurie, G.I., Matranga, D., et al. (2012). Intraoral electrostimulator for xerostomia relief: a long-term, multicenter, open-label, uncontrolled, clinical trial. ORAL SURGERY, ORAL MEDICINE, ORAL PATHOLOGY AND ORAL RADIOLOGY, 113(6), 773-781 [10.1016/j.oooo.2012.01.012].
File in questo prodotto:
File Dimensione Formato  
OOOO Intraoral electrostimulator for xerostomia relief- a long-term, multicenter, open-label, uncontrolled, clinical trial.pdf

Solo gestori archvio

Descrizione: Paper
Dimensione 915.11 kB
Formato Adobe PDF
915.11 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10447/63317
Citazioni
  • ???jsp.display-item.citation.pmc??? 9
  • Scopus 33
  • ???jsp.display-item.citation.isi??? 28
social impact